Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 368 of 6351
-
Experimental combo targets tough lung cancer
Disease control Recruiting nowThis open-label, Phase I/II trial is studying the safety and effectiveness of an experimental drug combination, lurbinectedin with osimertinib, against a rare type of cancer known as transformed small cell lung cancer (SCLC).
Phase 1/2 • Sponsor: Misty Shields • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Creatine may shield breast cancer patients from 'Chemo Brain'
Symptom relief Not yet recruitingThe goal of this clinical trial is to evaluate whether oral creatine supplementation can prevent chemotherapy-related cognitive impairment in patients with early-stage breast cancer undergoing neoadjuvant or adjuvant chemotherapy. The main questions it aims to answer are: * Does…
Phase 3 • Sponsor: D'Or Institute for Research and Education • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New drug targets brain tumors in lung cancer patients
Disease control Recruiting nowA single arm phase II study evaluating intracranial efficacy of tarlatamab in patients with asymptomatic active brain metastases from small cell lung cancer (SCLC).
Phase 2 • Sponsor: Maastricht University Medical Center • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Mind over matter: brain implant could restore digital independence for quadriplegics
Disease control Recruiting nowThe goal of this clinical trial is to demonstrate control of digital devices through a brain implant in people with spinal cord injury. The main question it aims to answer is efficient, independent, BCI-based control over digital devices in settings of daily living of an individu…
Sponsor: UMC Utrecht • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Can a video-based therapy transform hospital stays for autistic teens?
Disease control Not yet recruitingThis study is evaluating whether a telehealth-based applied behavior analysis (ABA) program can improve the care of adolescents and young adults with autism spectrum disorder (ASD) who are hospitalized because of severe challenging behaviors, such as aggression, self-injury, prop…
Sponsor: Caring Technologies, Inc. • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
Experimental drug targets bone marrow failure
Disease control Not yet recruitingThis is a multicenter, open-label, Phase 1/2 basket study to evaluate the safety and efficacy of Dibotatug (DR-01) in adults with Bone Marrow Failure syndromes.
Phase 1/2 • Sponsor: Dren Bio • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a triple threat of drug, immunotherapy, and radiation wipe out High-Risk urinary tract cancer before surgery?
Disease control Not yet recruitingThis is an open-label, single-arm, single-cohort, prospective clinical study evaluating neoadjuvant antibody-drug conjugate therapy combined with immunotherapy and sequential radiotherapy followed by radical surgery in patients with high-risk upper tract urothelial carcinoma (UTU…
Phase 2 • Sponsor: Peking University First Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Pocket-sized HIV test could bring same-day diagnosis to community clinics
Diagnosis Not yet recruitingThe goal of this cross-sectional study is to learn if the GeneXpert system is a practical system for HIV and STBBI testing in community-based organizations and health clinics. The study involves a clinical trial to learn if the HIV-1 Qual XC test works to identify HIV in near-pat…
Sponsor: Unity Health Toronto • Aim: Diagnosis
Last updated Jul 30, 2026 00:00 UTC
-
Can a special PET scan spot hidden prostate cancer after focal therapy?
Diagnosis Not yet recruitingTo determine the effectiveness of Posluma PET Scan for monitoring prostate cancer patients after targeted treatment, including how accurately it can detect any remaining or returning cancer after about 12 months post-treatment.
Phase 2 • Sponsor: Aditya Bagrodia • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
Robot companions may shield aging caregivers from frailty
Prevention Not yet recruitingBackground With population ageing accelerating worldwide, long-term care needs are rising, and family caregivers have become an essential yet often under-recognised component of care systems. Older family caregivers are particularly susceptible to frailty because they shoulder su…
Sponsor: The Hong Kong Polytechnic University • Aim: Prevention
Last updated Aug 02, 2026 00:00 UTC
-
Could popular opinion leaders be the key to HIV prevention?
Prevention Not yet recruitingThe Community Popular Opinion Leader (CPOL) is an intervention dveloped in the United States which identifies, trains, and enlists key opinion leaders within communities to deliver messages to peers and help link them to services. This project involves testing the feasibility and…
Sponsor: Africa Health Research Institute • Aim: Prevention
Last updated Aug 05, 2026 00:00 UTC
-
A dual sleep disorder: can one pill boost CPAP success?
Disease control Not yet recruitingCOMISA, the combination of obstructive sleep apnea (OSA) and insomnia, is a frequent and burdensome condition. Many patients with OSA experience clinically significant insomnia symptoms, and a substantial proportion of individuals with chronic insomnia also meet criteria for OSA.…
Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a single injection curb blood loss in fibroid surgery?
Disease control Not yet recruitingA myomectomy is a surgery to remove noncancerous growths (fibroids) from the uterus while keeping the uterus in place. This surgery can cause significant blood loss. Terlipressin is a medicine that narrows blood vessels and may help reduce bleeding. This study will test whether …
Sponsor: Sevil Cankaya • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
AI could sharpen the art of brain aneurysm repair
Knowledge-focused Not yet recruitingThis prospective, multicenter, observational registry study will evaluate the real-world safety, effectiveness, and clinical value of artificial intelligence (AI)-assisted microcatheter shaping during coil embolization of intracranial aneurysms. Adults with an intracranial aneur…
Sponsor: Xuanwu Hospital, Beijing • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC
-
A new twist on rehab: could restricted blood flow boost balance and joint awareness?
Disease control Not yet recruitingPosterior tibial tendon dysfunction (PTTD) is a common musculoskeletal disorder characterized by pain, impaired foot function, and reduced dynamic stability. As one of the primary causes of adult-acquired flatfoot deformity, it can significantly affect walking ability, balance, a…
Sponsor: May University in Cairo • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a spice and a mindset shift ease diabetic nerve pain?
Disease control Not yet recruitingThis randomized controlled trial aims to evaluate the therapeutic effects of pure Ceylon cinnamon (Cinnamomum verum) supplementation combined with a structured self-efficacy-based educational program on glycemic control, lipid profiles, and neuropathic pain in adult patients with…
Sponsor: Jerash Private University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can a nerve pacemaker tame Post-Cancer bowel chaos?
Disease control Not yet recruitingA randomized, prospective, multicenter, open-label, pragmatic pilot study of patients with Low Anterior Resection Syndrome treated early (\<120 days after discharge following intestinal bypass reconstruction) with sacral nerve root neuromodulation, compared with another group rec…
Sponsor: Hospital Universitari Vall d'Hebron Research Institute • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Could a vaccine help fight Hard-to-Treat cancers?
Disease control Recruiting nowThis study aims to determine the safety and maximum tolerated dose (MTD) of YMN-136 vaccine through a dose escalation trial, and to investigate whether YMN-136 vaccine can assist in the treatment of patients with advanced hepatobiliary and pancreatic malignancies.
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a new drug shrink Hard-to-Treat tumors?
Disease control Not yet recruitingStudy ATX-898-101 is a phase 1/2 open-label study evaluating the safety, tolerability, pharmacokinetic, and preliminary efficacy of ATX-898 as monotherapy and in combination with anti-neoplastic agents in selected solid tumors. This study consists of 2 parts. Part 1 evaluates ATX…
Phase 1/2 • Sponsor: Antares Therapeutics, Inc • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a collagen patch outperform fish skin in healing diabetic wounds?
Disease control Not yet recruitingThis is a randomized controlled clinical investigation in patients suffering from diabetic foot ulcers at multiple centres in India and Bangladesh. The study compares patient outcomes using standard wound care with a High Purity Type-I Collagen-Based Skin Substitute against stand…
Sponsor: Adichunchanagiri Institute of Medical Sciences, B G Nagara • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC